Newsroom

Recent News Releases

January 22, 2020 1/22/2020

Takeda Announces Liquidation of Holding Company

January 21, 2020 1/21/2020

Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running

January 14, 2020 1/14/2020

Takeda To Outline Progress on Business Transformation and Priorities at the 38^th Annual J.P. Morgan Healthcare Conference

January 8, 2020 1/8/2020

Takeda to Present at the 38^th Annual J.P. Morgan Healthcare Conference

December 20, 2019 12/20/2019

Takeda Receives Complete Response Letter from U.S. FDA for the Investigational Subcutaneous Formulation of ENTYVIO^® (vedolizumab) as a Maintenance Therapy in Adults with Moderate to Severe Ulcerative Colitis

SEE ALL NEWS AND RELEASES >

・For legacy Shire information, click here

Featured Topics

2019 – A Transformative Year for Takeda

LEARN MORE

Empowering women with Chronic Idiopathic Constipation to take control of their condition

LEARN MORE

Takeda CEO Sees a Bright Future in Globalized Pharmaceuticals Market

LEARN MORE

Universal Health Coverage and the Power of People: United Nations General Assembly Side Event

LEARN MORE

Grand opening of new Dengue vaccine manufacturing plant in Singen, Germany

LEARN MORE

SEE ALL FEATURED TOPICS ARTICLES >

In the News

With this new original series featured in Asahi Shimbun Globe, President & CEO Christophe Weber gives his unique perspective on what he has learned from his upbringing in France and his international career.

LEARN MORE

Executive Leadership

Meet our Executive Leadership Team led by our President and CEO, Christophe Weber

LEARN MORE

For media inquiries or reporter requests for more information, contact our Corporate Communications via Media_Relations@takeda.com. If you generally would like to contact us, please visit Contact Us.